The bumpy road from scientist to CEO

Friday June 28th, 12:00 - 13:00

Abstract

Toxys is a Dutch biotech company that offers a broad spectrum of innovative in vitro solutions in the field of genotoxicity, developmental and mechanistic toxicity screening. Toxys has developed the unique ToxTracker® assay, a high throughput stem cell-based reporter assay for carcinogenicity hazard identification. With this unique, patented ToxTracker assay, Toxys can not only identify toxic and potentially carcinogenic substances with a high accuracy, but also provide understanding why compounds are toxic. It is exactly this information that allows our customers to develop better and safer medicines and products. Currently, Toxys is providing its ToxTracker services to many major multinationals from pharma, cosmetics, chemistry and food industries all over the world.

But Toxys is still a young company. Toxys was founded in 2014 by Giel Hendriks, who worked for four years as a post-doctoral fellow in at Leiden University, studying the relationship between DNA damage and gene mutations. After these fundamental scientific projects, he made a switch and worked for six years as senior scientist at the Leiden University Medical Center on the development of in vitro reporter systems to detect and understand the mechanisms of genotoxicity. During this period, he has been instrumental in the development of the ToxTracker assay.
In 2014, Giel obtained pre-seed financing from NGI to start Toxys and to bring the ToxTracker assay to the market. As CEO of Toxys, he worked to develop the company into an internationally recognised contract research organisation (CRO) in genetic toxicology and chemical safety testing for the pharmaceutical, cosmetics and chemical industry. After winning the HollandBio BioBusiness Masterclass in 2015, in the beginning of 2016 he secured Seed financing from InnovationQuarter and the Zeeland Investment Fund to establish a new Toxys laboratory, further grow the company and continue the development of innovative in vitro cell assays for mechanistic toxicity screening.

About Giel Hendriks

CEO, Toxys
Giel Hendriks has a PhD in molecular biology from Utrecht University and worked for four years as a post-doctoral fellow in at Leiden University, studying the relationship between DNA damage and gene mutations. After this fundamental scientific projects he made a switch and worked for six years a senior scientist at the Leiden University Medical Center on the development of in vitro reporter systems to detect and understand the mechanisms of genotoxicity. During this period, he has been instrumental in the development of the ToxTracker assay.
In 2014, Giel obtained pre-seed financing from NGI to start Toxys and to bring the ToxTracker assay to the market. As CEO of Toxys, he worked to develop the company into an internationally recognised contract research organisation (CRO) in genetic toxicology and chemical safety testing
for the pharmaceutical, cosmetics and chemical industry.
After winning the HollandBio BioBusiness Masterclass in 2015, in the beginning of 2016 he secured Seed financing from InnovationQuarter and the Zeeland Investment Fund to establish a new Toxys laboratory, further grow the company and continue the development of innovative in
vitro cell assays for mechanistic toxicity screening.

Jumpstart your career

Join BioBusiness Summer School to jumpstart your career in Life Sciences by gaining knowledge of business aspects such as product development, IPR, finance and business models. The next edition of the summer school will be organised from 24-28 June 2019 in Amsterdam, the Netherlands.

Why participate

The BioBusiness Summer School is a programme tailored to bridge the gap. By immersing yourself in the business aspects of Life Sciences during this programme, you will learn the basic knowledge of BioBusiness, gain insight in the world of Life Sciences companies, meet leading business leaders and increase your international network.

Employers meet talent

Is your organisation interested in early-career talents in Life Sciences? BioBusiness Summer School can get you in touch with business oriented PhDs, postdocs or Master students. More info can be found here.